000			01790ngm a2200385 a 4500
001			HST4359
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			170217s2017 enk|||||||||||s|||v|eng d
028	5	0	_a4359 _bHenry Stewart Talks
035			_a(UkLoHST)3432
040			_aUkLoHST _beng _cUkLoHST
100	1		_aRaj, Nitya, _u(Memorial Sloan Kettering Cancer Center, USA) _4spk
245	1	0	_aImmunotherapy in neuroendocrine tumors _h[electronic resource] : _bpart 1 of 2, current available therapy options / _cNitya Raj.
246	3		_aCurrent available therapy options
246	3		_aImmunotherapy in neuroendocrine tumors. 1, Current available therapy options
260			_aLondon : _bHenry Stewart Talks, _c2017.
300			_a1 online resource (1 streaming video file (18 min.) : _bcolor, sound).
490	1		_aImmunotherapy of cancer, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: General background on neuroendocrine tumors (NETs) -- Medical management of NETs (current therapy options as of 2016 for extra-pancreatic NETs and pancreatic NETs) -- Factors associated with response to immunotherapy in cancer.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aImmunotherapy.
650		0	_aNeuroendocrine tumors _xTreatment.
650		2	_aImmunotherapy _xtrends.
650		2	_aNeuroendocrine Tumors _ximmunology.
650		2	_aNeuroendocrine Tumors _xtherapy.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection. _pImmunotherapy of cancer.
856	4	0	_uhttps://hstalks.com/bs/3432/
856	4	2	_uhttps://hstalks.com/bs/p/896/ _3Series
999			_c76568 _d76568